cyclopentane has been researched along with gw9662 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SY; Chung, HY; Chung, JH; Chung, SW; Kim, DH; Kim, JY; Yu, BP | 1 |
| Ajmone-Cat, MA; Bernardo, A; Bultel-Poncé, V; De Nuccio, C; Durand, T; Galano, JM; Greco, A; Guy, A; Lavinia Salvatori, M; Minghetti, L; Oger, C; Salvi, R; Visentin, S | 1 |
2 other study(ies) available for cyclopentane and gw9662
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma agonist action of 3-methyl-1,2-cyclopentanedione.
Topics: Anilides; Animals; Blotting, Western; Cell Line; Cyclopentanes; Down-Regulation; NF-kappa B; PPAR gamma; Rats | 2007 |
Nonenzymatic oxygenated metabolites of α-linolenic acid B1- and L1-phytoprostanes protect immature neurons from oxidant injury and promote differentiation of oligodendrocyte progenitors through PPAR-γ activation.
Topics: alpha-Linolenic Acid; Anilides; Cell Differentiation; Cell Line, Tumor; Central Nervous System; Cyclopentanes; Enzyme Activation; Fatty Acids, Unsaturated; Furans; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Neural Stem Cells; Neurons; Neuroprotective Agents; Oligodendroglia; Oxidative Stress; PPAR gamma | 2014 |